수의용 이미징 시장 보고서 : 제품 유형, 동물 유형, 용도, 최종사용자, 지역별(2025-2033년)

The global veterinary imaging market size reached USD 2.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.2 Billion by 2033, exhibiting a growth rate (CAGR) of 5.11% during 2025-2033. The increasing pet ownership, rising prevalence of chronic and acute conditions, ongoing technological advancements, and expanding number of veterinary hospitals are primarily driving the market's growth.

Veterinary imaging is a non-invasive means of identifying and monitoring diseases and injuries among animals. It relies on X-radiation (ray) imaging/radiography, ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine imaging. It helps establish a standard database of normal anatomical, physiological, and functional parameters that can be used for clinical and research purposes. At present, there is a widespread prevalence of cardiovascular diseases (CVDs) among animals, which is catalyzing the demand for veterinary imaging across the globe.

Veterinary Imaging Market Trends:

At present, there is a considerable increase in the number of pet parents around the world. This, in confluence with rising expenditures on pet health and insurance, represents one of the key factors propelling the growth of the market. Moreover, radiography represents one of the commonly used imaging procedures in veterinary practices as it assists in creating images of bones, foreign objects, and large body cavities and detecting fractures, tumors, injuries, infections, and deformities. This, coupled with the rising number of dogs with orthopedic disorders, is positively influencing the market. Additionally, livestock diseases lead to productivity losses, uncertain food security, loss of income, and negative impacts on human health. As a result, the demand for veterinary imaging is rising around the world. Apart from this, advancements in veterinary MRI technology are enabling the scanning of soft tissue structures before surgery. This, along with the rapid expansion of veterinary hospitals worldwide and the increasing development of portable and battery-powered imaging instruments for point-of-care services, is driving the market. Furthermore, the rising focus on one health approach, which recognizes that the health of humans, animals, and ecosystems are interconnected, is fueling the market growth.

Key Market Segmentation:

Breakup by Product Type:

• Instrument
• Reagents
• Others

Breakup by Animal Type:

• Small Companion Animals
• Large Animals

Breakup by Application:

• Orthopedics and Traumatology
• Oncology
• Cardiology
• Neurology
• Others

Breakup by End User:

• Hospitals and Clinics
• Reference Laboratories
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agfa-Gevaert N.V. (IG Farben), Canon Inc., Carestream Health Inc., Draminski S.A., Esaote SpA, Fujifilm holdings corp., Hallmarq Veterinary Imaging, Heska Corporation, IDEXX Laboratories Inc., IMV Technologies Group, MinXray Inc. and Siemens Healthineers AG (Siemens AG).

Key Questions Answered in This Report

• 1.What was the size of the global veterinary imaging market in 2024?
• 2.What is the expected growth rate of the global veterinary imaging market during 2025-2033?
• 3.What are the key factors driving the global veterinary imaging market?
• 4.What has been the impact of COVID-19 on the global veterinary imaging market?
• 5.What is the breakup of the global veterinary imaging market based on the product type?
• 6.What is the breakup of the global veterinary imaging market based on the animal type?
• 7.What is the breakup of the global veterinary imaging market based on the application?
• 8.What is the breakup of the global veterinary imaging market based on the end user?
• 9.What are the key regions in the global veterinary imaging market?
• 10.Who are the key players/companies in the global veterinary imaging market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Veterinary Imaging Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Instrument
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Reagents
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Others
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Animal Type

• 7.1 Small Companion Animals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Large Animals
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Application

• 8.1 Orthopedics and Traumatology
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Oncology
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Cardiology
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Neurology
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals and Clinics
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Reference Laboratories
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Agfa-Gevaert N.V. (IG Farben)
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Canon Inc.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 Carestream Health Inc.
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 SWOT Analysis
  • 15.3.4 Draminski S.A.
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Esaote SpA
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Fujifilm holdings corp.
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 Hallmarq Veterinary Imaging
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Heska Corporation
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 IDEXX Laboratories Inc.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 IMV Technologies Group
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 MinXray Inc.
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
  • 15.3.12 Siemens Healthineers AG (Siemens AG)
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio
    • 15.3.12.3 Financials
    • 15.3.12.4 SWOT Analysis